Stay informed with the latest press releases, industry updates, and insights from Innovative Medicines Canada.
In the news July 21, 2026
By Dr. Bettina Hamelin Article originally published on Healthing.ca, July 21, 2026. This spring, Canada made history when astronaut Jeremy Hansen […]
In the news June 25, 2026
By Dr. Bettina Hamelin Article originally published on healthinsight.ca, June 25, 2026. Global drug policy changes are making it increasingly difficult […]
In the news June 11, 2026
By Dr. Bettina Hamelin Article originally published on the Toronto Star, June 11, 2026. There’s a quiet crisis unfolding behind closed […]
In the news June 09, 2026
The global rules governing how innovative medicines are valued and priced are being rewritten— and Canada must be ready. By […]
In the news April 28, 2026
In this episode of From the Burgundy Chairs, Santis Health Senior Advisor Avis Favaro sits down with Dr. Bettina Hamelin, […]
In the news April 22, 2026
Article by Bettina Hamelin originally published in the Hill Times Health Policy Briefing, page 21, April 22, 2026. By Dr. […]
In the news April 10, 2026
As originally published in Investment Reports, featured by Newsweek on 10th April 2026 Over the past year, have you seen […]
In the news March 24, 2026
As originally published by Bettina Hamelin on LinkedIn on 24 March 2026 By Bettina Hamelin Recent global drug policy changes […]
In the news February 11, 2026
The new U.S. drug pricing approach forces a choice, but it doesn’t limit our ambition. We need a new, coordinated […]
In the news February 10, 2026
As originally published in NPC Healthbiz Weekly (Issue #356) in February 2026. Canada has the talent and industrial capacity to […]
In the news November 07, 2025
Health is Canada’s first line of defense. A country that cannot protect the health of its people cannot protect its […]
In the news October 16, 2025
Dr. Paul Wheatley-Price chats with IMC President & CEO, Dr. Bettina Hamelin in this episode, covering off what IMC does, the role of […]
Stay informed with timely, relevant content on key issues shaping our industry.
